Probiotics show promise in mitigating antibiotic-induced gut microbiota disruption, however, further research is needed to ...

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the ...

Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn's disease Primary endpoints met in ulcerative colitis (UC) and Crohn's disease (CD), the most ...

Sanofi and Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd., today announced that the RELIEVE UCCD phase 2b study met its primary endpoints in patients with ulcerative ...

After half-a-dozen surgeries, which resulted in him losing 28 kilograms, Cody Ramsey was a shell of himself. This is the ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center named top 5 in the nation for cancer by U.S. News ...

A musician who spent the last three Christmas periods in hospital on her own due to Crohn’s disease is hoping to “re-write ...

The drug and biotech sector saw a strong first half of 2024, driven by an increase in mergers and acquisitions (M&A), robust ...

IBDs are diseases in which the immune system becomes overactive and causes inflammation in the digestive tract. The immune ...

Teva and its partner Sanofi say 47.8% of patients with ulcerative colitis who received a high dose of their drug duvakitug experienced clinical remission, compared with 20.5% who received a placebo.

Perspire Sauna Studio, the country's largest full-spectrum infrared (IR) and red-light (RL) sauna therapy franchise, is ...

Duvakitug was generally well tolerated across patient groups and showed similar rates of treatment-emergent adverse events, ...